Integrated biomaterials approach that enhances adoptively transferred T cell therapy with cancer vaccine technology provides strong and long-lasting effects against solid tumors
An immune-infiltrated human kidney organoid-on-chip model enables assessment of kidney toxicities to immunotherapeutic T cell bispecific antibody drugs with high resolution
Harvard and the University of Zurich partner to create a next-generation heart valve that accurately functions upon implantation and regenerates into long-lasting heart-like tissue
First yeast biohybrid system using an adaptable light-harvesting semiconductor approach opens the door to more efficient and versatile biomanufacturing
